Allosteric drug discovery company Nutshell Therapeutics has raised $20 million in a Series A round led by Source Code Capital.
Currently the only platform-type allosteric drug discovery company in China driven by computational methods
@sourcecodecapital
创造持久真实价值
Currently the only platform-type allosteric drug discovery company in China driven by computational methods
In 2021, Hongjiang Zhang was ranked number one in mainland China among the world's top 1,000 computer scientists.
All-in-one cross-border e-commerce operations management system.
After six years of rapid growth, the platform now serves approximately 20,000 enterprise clients, with projected shipping volume expected to reach 700,000 TEUs in 2021.
The management system avoids a one-size-fits-all approach, staying flexible and adaptable rather than rigid.
Build a global children's brand born from China.
It has accumulated millions of paying users, covering more than 90% of domestic regions.
Stay in a posture of growth.
It was the first to propose the "nourish skin with oil" concept, and at one point broke into Tmall's top 10 serum category rankings.